Dengue: an update on treatment options
Related Experiment Video
Updated: Mar 29, 2026

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
Published on: April 28, 2019
Candice Y Y Chan1,2, Eng Eong Ooi
1Department of Infectious Diseases, Singapore General Hospital, Singapore.
Abstract:
Dengue is the most important mosquito-borne viral pathogen globally, with approximately 100 million cases of acute dengue annually. Infection can result in severe, life-threatening disease. Currently, there is no effective vaccine or licensed antiviral. Management is primarily supportive with fluids. Direct antiviral therapies that reduce dengue severity could be useful although these would need to inhibit all four viral serotypes effectively. This review focuses on the interventions that currently considered the gold standard in case management as well as exploratory therapies that have been studied in clinical trials. Although antiviral drug and therapeutic antibodies for dengue remain a work in progress, these studies have produced some promising results and may have the potential to be future drugs.
More Related Videos
Related Concept Videos
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Pharmaceutical Poisoning: Treatment Strategies
Venous Thrombosis III: Interprofessional Care
Anthelminthic Agents
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Rheumatic Heart Disease III: Medical Management

